Financhill
Sell
36

GSK Quote, Financials, Valuation and Earnings

Last price:
$48.99
Seasonality move :
6.89%
Day range:
$48.69 - $49.04
52-week range:
$31.72 - $49.44
Dividend yield:
3.42%
P/E ratio:
13.96x
P/S ratio:
2.40x
P/B ratio:
4.53x
Volume:
1.1M
Avg. volume:
4M
1-year change:
43.87%
Market cap:
$98.4B
Revenue:
$40.1B
EPS (TTM):
$3.51

Earnings Data

Next earnings date for GSK
Feb 04
2026
Most recent earnings per share
$1.32
Beat by $0.06
(Oct 29/2025)
Consensus Estimate
$1.26
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GSK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $11.3B -- -- $0.61 --
10/29/2025 Q3 $11B $11.5B $1.32 $1.26 $0.06
07/30/2025 Q2 $10.5B $10.7B $0.94 $1.11 -$0.17
04/30/2025 Q1 $10B $9.5B $0.99 $1.04 -$0.05
02/05/2025 Q4 $9.6B $10.4B $0.26 $0.49 -$0.23
10/30/2024 Q3 $10.4B $10.4B -$0.04 $1.16 -$1.20
07/31/2024 Q2 $9.6B $9.9B $0.72 $0.98 -$0.27
05/01/2024 Q1 $8.8B $9.3B $0.64 $0.94 -$0.29
01/31/2024 Q4 $9.7B $10B $0.21 $0.77 -$0.56
11/01/2023 Q3 $9.4B $10.3B $0.90 $1.14 -$0.24
07/26/2023 Q2 -- $9B $0.99 -- --
04/26/2023 Q1 -- $8.4B $0.89 -- --
02/01/2023 Q4 -- $8.7B $0.86 -- --
11/02/2022 Q3 -- $9.2B $6.22 -- --
07/27/2022 Q2 -- $8.7B $0.52 -- --
04/27/2022 Q1 -- $9.6B $1.19 -- --
02/09/2022 Q4 -- $9.5B $0.62 -- --
10/27/2021 Q3 -- $9.1B $0.79 -- --
07/28/2021 Q2 -- $8.2B $0.97 -- --
04/28/2021 Q1 -- $10.2B $0.73 -- --
02/03/2021 Q4 -- $11.5B $0.44 -- --
10/28/2020 Q3 -- $11.2B $0.80 -- --
07/29/2020 Q2 -- $9.5B $1.40 -- --
04/29/2020 Q1 -- $11.6B $1.00 -- --
02/05/2020 Q4 -- $11.4B $0.83 -- --
10/30/2019 Q3 -- $11.6B $0.96 -- --
07/24/2019 Q2 -- $10B $0.62 -- --
05/01/2019 Q1 -- $10B $0.54 -- --
02/06/2019 Q4 -- $10.5B $0.79 -- --
10/31/2018 Q3 -- $10.5B $0.93 -- --
07/25/2018 Q2 -- $9.9B $0.30 -- --
04/25/2018 Q1 -- $10.1B $0.39 -- --
02/07/2018 Q4 -- $10.1B -$0.37 -- --
10/25/2017 Q3 -- $10.3B $0.80 -- --
07/26/2017 Q2 -- $9.4B -$0.12 -- --
04/26/2017 Q1 -- $9.1B $0.66 -- --
02/08/2017 Q4 -- $9.4B $0.16 -- --
10/26/2016 Q3 -- $9.9B $0.54 -- --
07/27/2016 Q2 -- $9.3B -$0.32 -- --
04/27/2016 Q1 -- $8.8B $0.21 -- --
02/03/2016 Q4 -- $9.5B -$0.28 -- --

GSK Plc Earnings Questions

  • How Much did GSK Plc Generate in Revenue Last Quarter?

    GSK Plc reported $11.5B worth of top line sales in its most recent quarter.

  • Did GSK Plc Beat Earnings Last Quarter?

    GSK Plc announced earnings per share of $1.32 which represents a beat of analyst forecast a $1.26 per share.

  • Is GSK Plc Profitable?

    GSK Plc reported $8.5B that represents $4.15 per share over the last quarter.

  • What is the Analyst Consensus for GSK Plc EPS Next Year?

    GSK Plc's earnings are forecast to grow from $1.59 per share to $3.92 per share next year representing an increase of 169.11%.

  • When is GSK Plc's Earnings Date?

    GSK Plc's next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
56
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock